Abstract: The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease.
| # | Name | Date |
|---|---|---|
| 1 | 202417041337-STATEMENT OF UNDERTAKING (FORM 3) [28-05-2024(online)].pdf | 2024-05-28 |
| 3 | 202417041337-Sequence Listing in PDF [28-05-2024(online)].pdf | 2024-05-28 |
| 4 | 202417041337-REQUEST FOR EXAMINATION (FORM-18) [28-05-2024(online)].pdf | 2024-05-28 |
| 5 | 202417041337-POWER OF AUTHORITY [28-05-2024(online)].pdf | 2024-05-28 |
| 6 | 202417041337-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [28-05-2024(online)].pdf | 2024-05-28 |
| 7 | 202417041337-FORM 18 [28-05-2024(online)].pdf | 2024-05-28 |
| 8 | 202417041337-FORM 1 [28-05-2024(online)].pdf | 2024-05-28 |
| 9 | 202417041337-DRAWINGS [28-05-2024(online)].pdf | 2024-05-28 |
| 10 | 202417041337-DECLARATION OF INVENTORSHIP (FORM 5) [28-05-2024(online)].pdf | 2024-05-28 |
| 11 | 202417041337-COMPLETE SPECIFICATION [28-05-2024(online)].pdf | 2024-05-28 |
| 12 | 202417041337-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [28-05-2024(online)].pdf | 2024-05-28 |
| 13 | 202417041337-Proof of Right [23-07-2024(online)].pdf | 2024-07-23 |
| 14 | 202417041337-FORM 3 [24-09-2024(online)].pdf | 2024-09-24 |
| 15 | 202417041337-FORM 3 [07-10-2024(online)].pdf | 2024-10-07 |